MYLUNG Consortium Study Protocol 2

Running, not enrolling

Conditions studied: Carcinoma, Non-Small-Cell Lung

In brief

This pragmatic study looks to quantify the testing timeline, operational barriers, and outcomes of biomarker-guided therapy in a large, community-based, and largely unselected patient population with early stage and advanced stage, treatment-naive non-small cell lung cancer, whether squamous or non-squamous.

Key facts

Study ID

NCT05644808

Run by

US Oncology Research

People needed

1002

Starts

2020-12-29

Expected to finish

2027-12-01

Last updated by the study team

2026-05-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult subjects (18 years and older) with newly diagnosed early stage, locally advanced or metastatic non-small cell lung cancer
• Eligible for systemic therapy based on the treating provider's assessment
• Subjects who developed locally advanced or metastatic disease after receiving adjuvant or neoadjuvant therapy are eligible if the adjuvant/neoadjuvant therapy was completed at least 12 months prior to the development of locally advanced or metastatic disease
• Subjects may be enrolled within 30 days of initiation of systemic therapy
• Signed informed consent

You may not qualify if…

• Stage IA at the time of enrollment
• Subjects with small cell lung cancer
• Subjects with Unknown primary tumor origin

Where it is running

• Southern Cancer Center, PC — Daphne, Alabama, United States
• Rocky Mountain Cancer Center — Denver, Colorado, United States
• Woodlands Medical Specialists, PA — Pensacola, Florida, United States
• Illinois Cancer Specialists — Niles, Illinois, United States
• Maryland Oncology Hematology, P.A. — Silver Spring, Maryland, United States
• Minnesota Oncology Hematology, P.A. — Minneapolis, Minnesota, United States
• New York Oncology Hematology, P.C. — Albany, New York, United States
• Oncology Hematology Care Clinical Trials, LLC — Cincinnati, Ohio, United States
• Willamette Valley Cancer Institute and Research Center — Eugene, Oregon, United States
• Texas Oncology - West Texas — Abilene, Texas, United States
• Texas Oncology- DFWW — Arlington, Texas, United States
• Texas Oncology-Dallas Presbyterian Hospital — Dallas, Texas, United States
• Texas Oncology-Baylor Charles A. Sammons Cancer Center — Dallas, Texas, United States
• Texas Oncology - Fort Worth Cancer Center — Fort Worth, Texas, United States
• Texas Oncology-McAllen — McAllen, Texas, United States
• Texas Oncology- Northeast Texas — Tyler, Texas, United States
• Virginia Cancer Specialists, PC — Fairfax, Virginia, United States
• Virginia Oncology Associates — Newport News, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.